Company news

Shandong Buchang Pharmaceuticals Co., Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Announcement on Providing Guarantee for Holding Subsidiary

May 28, 2026

Announcement on Providing Guarantee for Wholly-owned Subsidiary

May 26, 2026

Announcement on the Change of Business Scope of Wholly-owned Subsidiary

May 25, 2026

Announcement on Progress in Holding Subsidiary's Proposed Signing of Intellectual Property Cooperation Agreement

May 19, 2026

Announcement on the Change of Domicile of Holding Subsidiary

May 14, 2026

Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction

May 13, 2026

Announcement on Release of Pledge of Partial Shares of Controlling Shareholders

May 12, 2026

Announcement on Progress in the Proposed Transfer of Holding Subsidiary Equity

May 11, 2026

Announcement on Receipt by its Holding Subsidiary of the Notice of Grant for the 2026 Project under the National Science and Technology Major Project for Prevention and Control of Emerging, Re-emerging and Major Infectious Diseases

May 8, 2026

Announcement on Change of Drug Production License of the Company and Wholly-owned Subsidiary

April 28, 2026

Announcement on 2025 Final Profit Distribution and Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Prepare the 2026 Interim Dividend Plan

April 27, 2026

Announcement on Obtaining Malaysian Drug Registration Certificate for Yangzhengheji Decoction

April 8, 2026

Announcement on Resolutions of the 46th Meeting of the 5th Board of Directors

April 7, 2026

Announcement on the Transfer of Holding Subsidiary Equity

March 12, 2026

Announcement on Participation in the Auction for the Qualification as a Restructuring Investor and Its Results

February 25, 2026

Announcement on Partial Drugs of the Subsidiary Being Selected for National Procurement Continuation After the Expiry of Agreement

February 11, 2026

Announcement on Pledge Release and Re-pledge of Partial Shares Held by Controlling Shareholder

February 10, 2026

Announcement on Resolutions of the 43rd Meeting of the 5th Board of Directors

February 9, 2026

Announcement on Progress in Proposed Waiver of Preemptive Rights for Equity of Holding Subsidiary and Related Party Transactions

February 4, 2026

Announcement on Wholly-owned Subsidiary Completing Industrial and Commercial Change Registration

February 2, 2026

Earnings Preannouncement for 2025

January 27, 2026

Announcement on the Plan of Share Repurchase through Call Auction and Obtaining of Commitment Letter on Special Loan for Repurchase from Financial Institution

January 16, 2026

Announcement on Holding Subsidiary Completing Industrial and Commercial Change Registration

January 7, 2026

Indicative Announcement on Changes in Fair Value of Trading Financial Assets

January 6, 2026

Announcement on the Recognition of Wholly-owned Subsidiary as a High-tech Enterprise Again

January 5, 2026

Announcement on Pledge of Controlling Shareholders' Shares

December 30, 2025

Announcement on the Execution of an Exclusive Supply Agreement between Holding Subsidiary Luzhou Buchang and MEDISPEC

December 29, 2025

Announcement on the Proposed Execution of a Technology Transfer Agreement by Wholly-owned Subsidiary Shandong Danhong with Shaanxi Functional Food Engineering Center Co., Ltd.

December 24, 2025

← Newer news releases